Express News | Taysha Gene Therapies Down 10.9%, Solid Biosciences Down 7.2%, US-Listed Shares of CRISPR Therapeutics Down 3.8%, Beam Therapeutics Down 3.2% Premarket

ReutersMar 31 05:43 ET

Express News | Shares of Gene Therapy Makers and Developers Fall Premarket After Report That FDA Official Peter Marks Has Resigned

ReutersMar 31 05:42 ET

JMP Securities Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsMar 21 04:31 ET · Ratings

Promising Clinical Trial Data and Market Conditions Boost Buy Rating for Solid Biosciences

TipRanksMar 20 11:15 ET · Ratings

Sarepta Safety Update on Elevidys Boosts Regenxbio, Hurts Solid Bio

Seeking AlphaMar 18 15:22 ET

Solid Biosciences Inc. (SLDB): Among Top Insider Purchases Last Month

Yahoo FinanceMar 14 22:29 ET